By: ABRS- Clinical Insights Team
Abstract
Introduction
Functional Service Provider (FSP) models have become an established part of clinical development strategy because they can provide sponsors with flexibility and access to specialized expertise without requiring every capability to be maintained internally. Industry Standard Research (2023) reported that sponsors using internal-plus-FSP models most commonly associated the approach with greater resource flexibility, while other functional outsourcing configurations were valued for access to skills and expertise not readily available within the organization. These findings suggest that the strategic value of FSP extends beyond adding personnel; it also lies in how external functional capability complements the sponsor’s existing clinical infrastructure.
That distinction is important because headcount alone does not indicate whether a team has the capability required to support increasingly complex clinical programs. Sonstein et al. (2024) describe clinical research competence as multidimensional, encompassing areas such as study operations, site management, leadership, communication, teamwork, and professional conduct. From an FSP perspective, this means that two individuals carrying the same job title may contribute very differently depending on their experience, level of independence, communication skills, and ability to operate effectively within a specific clinical environment.
Integration is therefore as important as qualification. Cranfill et al. (2023) demonstrated that competency-based onboarding can be strengthened when core training is combined with role-specific learning paths and a clearer understanding of how individual responsibilities connect with organizational workflows. Although their work was conducted in an academic research setting rather than an FSP model, the underlying principle is highly relevant: technical competence alone does not automatically translate into operational effectiveness. Professionals also need context about the systems, processes, expectations, and teams with which they will work.
Current Good Clinical Practice expectations reinforce this point. The International Council for Harmonisation (ICH, 2025) emphasizes that individuals performing trial-related activities should be appropriately qualified and that sponsors remain responsible for ensuring appropriate oversight when activities are transferred to service providers. Viewed through this lens, an FSP model should not be treated simply as a mechanism for filling positions. It is an operating model that must connect qualified professionals, clearly defined responsibilities, sponsor-specific processes, and effective oversight.
For organizations such as ABRS, this capability-based perspective is especially relevant because the objective of an integrated FSP approach is not merely to supply resources, but to support functional teams that can operate within the sponsor’s clinical environment while remaining aligned with broader program needs. The sections that follow examine why FSP should be understood as an operating model rather than a staffing solution, how functional expertise and sponsor-specific knowledge contribute to integration, how capacity can scale without fragmenting execution, and how individual resources can develop into broader functional capability.
Why FSP Is an Operating Model, Not Just a Staffing Model
Functional Expertise and Sponsor-Specific Knowledge
Functional expertise is essential in an FSP model, but expertise alone does not guarantee effective integration. A professional may have strong experience in monitoring, study management, data management, or another clinical function and still require time to understand how a particular sponsor operates. Systems, standard operating procedures, escalation pathways, communication expectations, decision rights, and internal workflows can differ significantly across organizations. For this reason, functional capability is strengthened when technical expertise is combined with sponsor-specific operational knowledge.
Sonstein et al. (2024) emphasize that clinical research competency extends beyond technical knowledge to include communication, leadership, teamwork, and the ability to apply judgment within the research environment. From an FSP perspective, this broader definition of competency is particularly relevant. Professionals embedded within sponsor teams must not only understand their functional responsibilities but also know how their work interacts with adjacent functions, when decisions can be made independently, and when an issue requires escalation or broader cross-functional involvement.
The importance of contextual integration is also reflected in the work of Cranfill et al. (2023), who evaluated a competency-based onboarding program for clinical research professionals. Their model combined standardized foundational learning with role-specific training and organizational context. The authors found value in tailoring onboarding to the responsibilities and workflows associated with each role rather than relying on a uniform training approach. Although their research was conducted within an academic clinical research environment, the principle is transferable to FSP integration: qualified professionals are more likely to contribute effectively when onboarding helps them understand both their role and the operating environment around it.
This distinction is also consistent with ICH E6(R3). The International Council for Harmonisation (ICH, 2025) emphasizes that individuals performing trial-related activities should be appropriately qualified through education, training, and experience and should have access to the information required to perform their assigned responsibilities. For FSP teams, this means qualification should not be viewed only as experience gained before assignment. Effective integration also requires ensuring that professionals understand the sponsor-specific information, systems, and processes necessary to perform their role within that particular program.
Sponsor-specific knowledge can therefore become an important source of continuity and efficiency over time. As embedded professionals become familiar with internal processes, study portfolios, communication structures, and stakeholder expectations, less effort may be required to repeatedly re-establish basic operating context. This can allow functional teams to focus more quickly on study-specific priorities and emerging operational needs.
In a mature FSP model, functional expertise and sponsor integration should reinforce one another. The objective is not to replace professional judgment with rigid standardization, but to create enough shared context that qualified individuals can apply their expertise effectively within the sponsor’s clinical environment.
Scaling Capacity Without Fragmenting Clinical Operations
One of the central advantages of an FSP model is the ability to expand or adjust functional capacity as program needs change. However, scalability creates value only when growth does not introduce fragmentation across teams, systems, responsibilities, and decision-making. Adding more resources can increase executional capacity, but without a shared operating structure it can also create duplicated work, inconsistent communication, and uncertainty about ownership.
Industry Standard Research (2023) identified flexibility as one of the principal benefits associated with FSP-based outsourcing models. From an operational perspective, that flexibility is most valuable when sponsors can adapt functional support to changing portfolio demands without repeatedly rebuilding the way teams work together. Scaling, therefore, is not simply a question of adding personnel. It also requires preserving consistency in roles, communication pathways, sponsor processes, and performance expectations as the team evolves.
The Association of Clinical Research Organizations (ACRO, 2026) provides a useful perspective on this challenge through its review of risk-based quality management practices. ACRO notes that when clinical trial activities are distributed across multiple functions or providers, effective coordination becomes increasingly important because quality activities must remain connected across the study rather than operating in isolation. Although its findings are focused on RBQM, the broader operational implication is relevant to FSP: specialized functional teams create greater value when their activities are integrated into an end-to-end operating framework rather than managed as separate workstreams.
This need for integration is reinforced by current GCP expectations. The International Council for Harmonisation (ICH, 2025) emphasizes that sponsors should clearly define transferred trial-related activities and maintain appropriate oversight of service providers. From the perspective of scalable FSP operations, these expectations highlight why growth must be accompanied by clear accountability. As additional professionals, functions, or regions are introduced, sponsors still need visibility into who is responsible for each activity, how information moves across the program, and how issues are escalated and resolved.
A capability-based FSP model therefore scales through more than workforce expansion. It also scales the operating structure around that workforce. Consistent onboarding, defined role boundaries, shared processes, established communication channels, and sponsor-specific ways of working can help new resources become productive without creating parallel structures that disconnect them from the broader clinical organization.
For ABRS, this principle is relevant to how an integrated FSP model can support evolving sponsor needs while maintaining alignment across functions. The objective is not simply to increase capacity as demand grows, but to preserve the operational connections that allow functional teams to work as part of a coordinated clinical program. In this sense, scalability is strongest when additional capability can be introduced without sacrificing continuity, visibility, or integration.
From Individual Resources to Integrated Functional Capability
The long-term value of an FSP model is realized when individual expertise becomes part of a broader functional capability. A sponsor may begin with the need for a CRA, study manager, data professional, or another specialized role, but the operational objective extends beyond filling that position. Over time, the stronger model is one in which professionals understand how their responsibilities connect with adjacent functions, share common expectations, and contribute within an established clinical operating structure.
Sonstein et al. (2024) describe clinical research competency as multidimensional, combining technical knowledge with capabilities such as communication, leadership, teamwork, and professional judgment. From an FSP perspective, this suggests that capability should not be assessed solely at the individual level. The effectiveness of a functional team also depends on whether those competencies can be applied collectively across interfaces, decisions, and study activities. A group of technically qualified professionals does not automatically become an integrated functional team; integration requires shared context and an understanding of how individual responsibilities contribute to broader clinical objectives.
Structured development and onboarding can help create that connection. Cranfill et al. (2023) found that competency-based onboarding can combine common foundational learning with role-specific pathways tailored to the responsibilities of clinical research professionals. Applied to FSP environments, this supports an approach in which new team members are not simply introduced to a role, but progressively connected to sponsor workflows, expectations, systems, and functional interfaces. As this knowledge becomes established, teams can develop greater consistency in how they communicate, prioritize work, and respond to operational needs.
Integration also becomes increasingly important as responsibilities are distributed across multiple teams or providers. The Association of Clinical Research Organizations (ACRO, 2026), in its assessment of risk-based quality management practices, emphasizes the importance of coordinating activities across functions rather than treating quality processes as isolated components. Although the report focuses specifically on RBQM, its broader implication is relevant to FSP design: specialized capability is more useful when it remains connected to the other functions that influence trial execution.
The same principle is consistent with ICH E6(R3). The International Council for Harmonisation (ICH, 2025) reinforces the need for appropriately qualified personnel, clearly defined trial-related activities, suitable service providers, and sponsor oversight of transferred responsibilities. These expectations point toward an operating model in which individual competence and organizational structure must work together. Qualification establishes whether a professional can perform an activity; integration helps ensure that the activity is performed within the appropriate clinical, operational, and quality context.
This is where FSP can evolve from resource augmentation into sustainable functional capability. When expertise, sponsor-specific knowledge, governance, and cross-functional coordination are developed together, teams can become more than a collection of individual assignments. Within broader support structures such as ABRS’s FullSpectrum model, the same capability-based principle can help connect functional expertise across changing program needs while keeping support aligned with the sponsor’s clinical operating environment.
Ultimately, the maturity of an FSP model is reflected not only in how effectively it can provide qualified professionals, but in how successfully those professionals become part of a connected functional system. Capacity answers the question of whether resources are available. Capability addresses whether the organization can translate those resources into coordinated, sustainable clinical execution.
Conclusion
References
Association of Clinical Research Organizations. (2026). RBQM survey summary report: ACRO’s 7-year landscape survey examines trends in risk-based approaches in clinical trials. ACRO.
Access the ACRO report
Cranfill, J. R., Deeter, C. E., Hannah, D., Snyder, D. C., & Freel, S. A. (2023). Development and implementation of an on-demand competency-based onboarding program for clinical research professionals in academic medicine. Frontiers in Medicine, 10, 1249527. https://doi.org/10.3389/fmed.2023.1249527.
Access the open-access article
Industry Standard Research. (2023, September 1). Benefits of clinical development outsourcing models. Life Science Leader.
Access the article
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (2025). ICH harmonised guideline: Good clinical practice E6(R3). ICH. The guideline reached Step 4 on January 6, 2025.
Access the official ICH E6(R3) guideline
Sonstein, S. A., Silva, H., Jones, C. T., & Bierer, B. E. (2024). Education and training of clinical research professionals and the evolution of the Joint Task Force for Clinical Trial Competency. Frontiers in Pharmacology, 15, 1291675. https://doi.org/10.3389/fphar.2024.1291675.
Access the open-access article
